MASSDEVICE ON CALL — Baxter (NYSE:BAX) closed the books on a federal bribery investigation after regulators dropped the probe without finding wrongdoing, the company announced.

The investigation was part of an industry-wide foreign bribery inquiry in which regulators from the SEC and the DOJ asked medical device makers to voluntarily review their own overseas operations.

Federal officials started taking a closer look at Baxter’s operations in China after the company reported expense violations from 2012, according to the Wall Street Journal. Anonymous tips claimed that the company was involved with bribery overseas, but the instigation closed last month without any punitive actions against the company.

 New medical coding is costly, docs say
The American Medical Assn. warned that the new ICD-10 coding rules could prove very costly for physicians and medical offices, representing a cost of as much as $8 million for larger groups.
Read more

 New nano-materials hint at a "cyborg" future, researchers say
New medical coatings could allow implanted nano-electronics to last much longer in the human body, heralding a future in which humans tiny medical implants interface with the human body, detecting diseases and helping to regulate bodily functions.
Read more

 Hospitals are on the outside looking in to Obamacare’s ACOs
One unanticipated consequence of the accountable care organizations formed under new healthcare reform initiatives is that hospitals are being excluded from physician-led groups, turning the ACO model on its head.
 
Read more

 Vermont reconsiders letting industry buy doc dinners
Vermont regulators are taking another look at gift bans, potentially allowing device makers and other healthcare industries to provide physicians with meals as long as they’re consumed in doctors’ offices.  
Read more